|
Aurobindo Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
91749.23 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
652.39
|
|
52 Week High/Low (Rs.)
|
1637/1016
|
FV/ML
|
1/1
|
P/E(X)
|
26.18
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.25
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 60.34 | 59.81 | 54.16 | 32.90 | 45.19 |
| Diluted EPS (Rs.) | 60.34 | 59.81 | 54.16 | 32.90 | 45.19 |
| Cash EPS (Rs.) | 90.90 | 88.92 | 80.35 | 54.34 | 64.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 652.39 | 562.21 | 509.49 | 458.30 | 419.42 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 652.39 | 562.21 | 509.49 | 458.30 | 419.42 |
| Revenue From Operations / Share (Rs.) | 579.43 | 546.21 | 495.00 | 424.23 | 400.33 |
| PBDIT / Share (Rs.) | 126.34 | 124.05 | 109.24 | 68.43 | 80.34 |
| PBIT / Share (Rs.) | 95.72 | 95.65 | 83.27 | 47.19 | 61.11 |
| PBT / Share (Rs.) | 87.99 | 87.78 | 75.05 | 44.79 | 58.10 |
| Net Profit / Share (Rs.) | 60.29 | 60.52 | 54.38 | 33.10 | 45.71 |
| NP After MI And SOA / Share (Rs.) | 60.34 | 60.02 | 54.16 | 32.90 | 45.20 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 21.80 | 22.71 | 22.06 | 16.13 | 20.06 |
| PBIT Margin (%) | 16.52 | 17.51 | 16.82 | 11.12 | 15.26 |
| PBT Margin (%) | 15.18 | 16.06 | 15.16 | 10.55 | 14.51 |
| Net Profit Margin (%) | 10.40 | 11.08 | 10.98 | 7.80 | 11.41 |
| NP After MI And SOA Margin (%) | 10.41 | 10.98 | 10.94 | 7.75 | 11.29 |
| Return on Networth / Equity (%) | 9.24 | 10.67 | 10.63 | 7.18 | 10.77 |
| Return on Capital Employeed (%) | 13.73 | 15.82 | 14.84 | 9.73 | 13.89 |
| Return On Assets (%) | 5.99 | 7.00 | 7.03 | 4.83 | 7.80 |
| Long Term Debt / Equity (X) | 0.02 | 0.04 | 0.07 | 0.02 | 0.01 |
| Total Debt / Equity (X) | 0.20 | 0.24 | 0.21 | 0.18 | 0.09 |
| Asset Turnover Ratio (%) | 0.62 | 0.66 | 0.68 | 0.67 | 0.69 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.81 | 1.85 | 1.98 | 1.87 | 2.22 |
| Quick Ratio (X) | 1.15 | 1.13 | 1.18 | 1.13 | 1.30 |
| Inventory Turnover Ratio (X) | 2.98 | 3.12 | 1.18 | 1.20 | 0.88 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 22.79 | 9.95 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 13.85 | 6.98 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 77.21 | 90.05 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 86.15 | 93.02 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 19.11 | 15.76 | 22.09 | 28.54 | 96.77 |
| Interest Coverage Ratio (Post Tax) (%) | 10.29 | 8.69 | 12.66 | 14.80 | 58.70 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 73487.61 | 67055.18 | 63875.80 | 29138.94 | 37374.61 |
| EV / Net Operating Revenue (X) | 2.18 | 2.11 | 2.20 | 1.17 | 1.59 |
| EV / EBITDA (X) | 10.01 | 9.31 | 9.98 | 7.27 | 7.94 |
| MarketCap / Net Operating Revenue (X) | 2.25 | 2.12 | 2.20 | 1.22 | 1.67 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 77.20 | 90.04 |
| Price / BV (X) | 2.00 | 2.06 | 2.14 | 1.13 | 1.59 |
| Price / Net Operating Revenue (X) | 2.25 | 2.12 | 2.20 | 1.22 | 1.67 |
| EarningsYield | 0.04 | 0.05 | 0.04 | 0.06 | 0.06 |
